Global burden of COPD: Systematic review and meta-analysis

R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A (Sonia) Buist, D. M. Mannino

Research output: Contribution to journalArticle

912 Citations (Scopus)

Abstract

The aim of this study was to quantify the global prevalence of chronic obstructive pulmonary disease (COPD) by means of a systematic review and random effects meta-analysis. PubMed was searched for population-based prevalence estimates published during the period 1990-2004. Articles were included if they: 1) provided total population or sex-specific estimates for COPD, chronic bronchitis and/or emphysema; and 2) gave method details sufficiently clearly to establish the sampling strategy, approach to diagnosis and diagnostic criteria. Of 67 accepted articles, 62 unique entries yielded 101 overall prevalence estimates from 28 different counties. The pooled prevalence of COPD was 7.6% from 37 studies, of chronic bronchitis alone (38 studies) was 6.4% and of emphysema alone (eight studies) was 1.8%. The pooled prevalence from 26 spirometric estimates was 8.9%. The most common spirometric definitions used were those of the Global Initiative for Chronic Obstructive Lung Disease (13 estimates). There was significant heterogeneity, which was incompletely explained by subgroup analysis (e.g. age and smoking status). The prevalence of physiologically defined chronic obstructive pulmonary disease in adults aged ≥40 yrs is ∼9-10%. There are important regional gaps, and methodological differences hinder interpretation of the available data. The efforts of the Global Initiative for Chronic Obstructive Lung Disease and similar groups should help to standardise chronic obstructive pulmonary disease prevalence measurement.

Original languageEnglish (US)
Pages (from-to)523-532
Number of pages10
JournalEuropean Respiratory Journal
Volume28
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Chronic Obstructive Pulmonary Disease
Meta-Analysis
Chronic Bronchitis
Emphysema
PubMed
Population
Smoking

Keywords

  • Chronic bronchitis
  • Chronic obstructive pulmonary disease
  • Emphysema
  • Meta-analysis
  • Prevalence
  • Spirometry

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006). Global burden of COPD: Systematic review and meta-analysis. European Respiratory Journal, 28(3), 523-532. https://doi.org/10.1183/09031936.06.00124605

Global burden of COPD : Systematic review and meta-analysis. / Halbert, R. J.; Natoli, J. L.; Gano, A.; Badamgarav, E.; Buist, A (Sonia); Mannino, D. M.

In: European Respiratory Journal, Vol. 28, No. 3, 09.2006, p. 523-532.

Research output: Contribution to journalArticle

Halbert, RJ, Natoli, JL, Gano, A, Badamgarav, E, Buist, AS & Mannino, DM 2006, 'Global burden of COPD: Systematic review and meta-analysis', European Respiratory Journal, vol. 28, no. 3, pp. 523-532. https://doi.org/10.1183/09031936.06.00124605
Halbert, R. J. ; Natoli, J. L. ; Gano, A. ; Badamgarav, E. ; Buist, A (Sonia) ; Mannino, D. M. / Global burden of COPD : Systematic review and meta-analysis. In: European Respiratory Journal. 2006 ; Vol. 28, No. 3. pp. 523-532.
@article{32e2ea5b661f4f6d88849270ea0c0bfe,
title = "Global burden of COPD: Systematic review and meta-analysis",
abstract = "The aim of this study was to quantify the global prevalence of chronic obstructive pulmonary disease (COPD) by means of a systematic review and random effects meta-analysis. PubMed was searched for population-based prevalence estimates published during the period 1990-2004. Articles were included if they: 1) provided total population or sex-specific estimates for COPD, chronic bronchitis and/or emphysema; and 2) gave method details sufficiently clearly to establish the sampling strategy, approach to diagnosis and diagnostic criteria. Of 67 accepted articles, 62 unique entries yielded 101 overall prevalence estimates from 28 different counties. The pooled prevalence of COPD was 7.6{\%} from 37 studies, of chronic bronchitis alone (38 studies) was 6.4{\%} and of emphysema alone (eight studies) was 1.8{\%}. The pooled prevalence from 26 spirometric estimates was 8.9{\%}. The most common spirometric definitions used were those of the Global Initiative for Chronic Obstructive Lung Disease (13 estimates). There was significant heterogeneity, which was incompletely explained by subgroup analysis (e.g. age and smoking status). The prevalence of physiologically defined chronic obstructive pulmonary disease in adults aged ≥40 yrs is ∼9-10{\%}. There are important regional gaps, and methodological differences hinder interpretation of the available data. The efforts of the Global Initiative for Chronic Obstructive Lung Disease and similar groups should help to standardise chronic obstructive pulmonary disease prevalence measurement.",
keywords = "Chronic bronchitis, Chronic obstructive pulmonary disease, Emphysema, Meta-analysis, Prevalence, Spirometry",
author = "Halbert, {R. J.} and Natoli, {J. L.} and A. Gano and E. Badamgarav and Buist, {A (Sonia)} and Mannino, {D. M.}",
year = "2006",
month = "9",
doi = "10.1183/09031936.06.00124605",
language = "English (US)",
volume = "28",
pages = "523--532",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - Global burden of COPD

T2 - Systematic review and meta-analysis

AU - Halbert, R. J.

AU - Natoli, J. L.

AU - Gano, A.

AU - Badamgarav, E.

AU - Buist, A (Sonia)

AU - Mannino, D. M.

PY - 2006/9

Y1 - 2006/9

N2 - The aim of this study was to quantify the global prevalence of chronic obstructive pulmonary disease (COPD) by means of a systematic review and random effects meta-analysis. PubMed was searched for population-based prevalence estimates published during the period 1990-2004. Articles were included if they: 1) provided total population or sex-specific estimates for COPD, chronic bronchitis and/or emphysema; and 2) gave method details sufficiently clearly to establish the sampling strategy, approach to diagnosis and diagnostic criteria. Of 67 accepted articles, 62 unique entries yielded 101 overall prevalence estimates from 28 different counties. The pooled prevalence of COPD was 7.6% from 37 studies, of chronic bronchitis alone (38 studies) was 6.4% and of emphysema alone (eight studies) was 1.8%. The pooled prevalence from 26 spirometric estimates was 8.9%. The most common spirometric definitions used were those of the Global Initiative for Chronic Obstructive Lung Disease (13 estimates). There was significant heterogeneity, which was incompletely explained by subgroup analysis (e.g. age and smoking status). The prevalence of physiologically defined chronic obstructive pulmonary disease in adults aged ≥40 yrs is ∼9-10%. There are important regional gaps, and methodological differences hinder interpretation of the available data. The efforts of the Global Initiative for Chronic Obstructive Lung Disease and similar groups should help to standardise chronic obstructive pulmonary disease prevalence measurement.

AB - The aim of this study was to quantify the global prevalence of chronic obstructive pulmonary disease (COPD) by means of a systematic review and random effects meta-analysis. PubMed was searched for population-based prevalence estimates published during the period 1990-2004. Articles were included if they: 1) provided total population or sex-specific estimates for COPD, chronic bronchitis and/or emphysema; and 2) gave method details sufficiently clearly to establish the sampling strategy, approach to diagnosis and diagnostic criteria. Of 67 accepted articles, 62 unique entries yielded 101 overall prevalence estimates from 28 different counties. The pooled prevalence of COPD was 7.6% from 37 studies, of chronic bronchitis alone (38 studies) was 6.4% and of emphysema alone (eight studies) was 1.8%. The pooled prevalence from 26 spirometric estimates was 8.9%. The most common spirometric definitions used were those of the Global Initiative for Chronic Obstructive Lung Disease (13 estimates). There was significant heterogeneity, which was incompletely explained by subgroup analysis (e.g. age and smoking status). The prevalence of physiologically defined chronic obstructive pulmonary disease in adults aged ≥40 yrs is ∼9-10%. There are important regional gaps, and methodological differences hinder interpretation of the available data. The efforts of the Global Initiative for Chronic Obstructive Lung Disease and similar groups should help to standardise chronic obstructive pulmonary disease prevalence measurement.

KW - Chronic bronchitis

KW - Chronic obstructive pulmonary disease

KW - Emphysema

KW - Meta-analysis

KW - Prevalence

KW - Spirometry

UR - http://www.scopus.com/inward/record.url?scp=33748677876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748677876&partnerID=8YFLogxK

U2 - 10.1183/09031936.06.00124605

DO - 10.1183/09031936.06.00124605

M3 - Article

C2 - 16611654

AN - SCOPUS:33748677876

VL - 28

SP - 523

EP - 532

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 3

ER -